Sorrento Therapeutics, Inc. Investor relations (IR) website contains information about our business for stockholders, potential investors, and financial ...
People also ask
Will Sorrento Therapeutics be delisted?
What is the future of SRNE stock?
Why is Sorrento Therapeutics stock so low?
Did Sorrento Therapeutics get a buyout offer?
Sorrento Therapeutics. Search. Who We Are · Overview · Leadership · Contact. Search for: en ... © 2024 Sorrento Therapeutics, Inc. All Rights Reserved. Terms of ...
The number of shares of the issuer's common stock, par value $0.0001 per share, outstanding as of April 29, 2022 was 388,946,453 . Sorrento Therapeutics, Inc.
Get the latest insights on SRNEQ (SRNEQ) with press releases and corporate news to help you in your trading and investing decisions.
Sorrento Therapeutics. Ticker SRNE. Exchange NASDAQ ... Sorrento Therapeutics is an antibody-centric, clinical ... 2021 Annual Report View Annual Report Download.
Missing: investor relations
Our common stock is listed on the Nasdaq Capital Market under the symbol “SRNE”. ... Annual Report on Form 10-K ... investor relations, marketing and medical ...
Sorrento Therapeutics (SRNE) Investor Presentation - Slideshow · SA TranscriptsFri, Mar. 12, 20213 Comments · Sorrento Therapeutics, Inc. (SRNE) CEO Henry Ji ...
Missing: relations | Show results with:relations
Feb 13, 2023 · Sorrento Therapeutics (SRNE) has filed for Chapter 11 bankruptcy. State Street (STT) is the largest shareholder of the company with a 49.84 ...